| |
| |
|
| Insider
Information: |
Herskowitz Neil |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
431,265 |
|
|
Indirect Shares
|
51,265 |
|
|
| Direct
Value |
$1,690,106 |
|
|
|
Indirect Value
|
$920,719 |
|
|
| Total
Shares |
482,530 |
|
|
| Total
Value |
$2,610,825 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
TG Therapeutics Inc |
TGTX |
Director |
2014-06-06 |
80,088 |
2012-12-06 |
51,265 |
Premium* |
|
|
Cb Pharma Acquisition Corp. |
CNLMU |
Director |
2016-05-20 |
0 |
|
0 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
Director |
2023-06-13 |
35,123 |
2017-06-15 |
0 |
Premium* |
|
|
Avenue Therapeutics, Inc. |
ATXI |
Director |
2021-12-17 |
183,744 |
|
0 |
Premium* |
|
|
National Holdings Corp |
NHLD |
Director |
2019-02-13 |
60,593 |
2019-02-12 |
0 |
Premium* |
|
|
Journey Medical Ord Shs |
DERM |
Director |
2023-07-21 |
71,717 |
2022-01-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2017-03-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2017-10-09 |
4 |
B |
$5.24 |
$2,620 |
D/D |
500 |
50,500 |
2.31 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2017-10-17 |
4 |
B |
$5.01 |
$5,010 |
D/D |
1,000 |
51,500 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2018-04-25 |
4 |
B |
$3.80 |
$3,800 |
D/D |
1,000 |
52,500 |
2.31 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2018-08-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
14,663 |
67,163 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-01-28 |
4 |
B |
$5.84 |
$8,450 |
D/D |
1,447 |
68,610 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-01-29 |
4 |
B |
$5.91 |
$50,548 |
D/D |
8,553 |
77,163 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-01-30 |
4 |
B |
$5.91 |
$3,842 |
D/D |
650 |
77,813 |
2.31 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-02-04 |
4 |
B |
$5.91 |
$41,370 |
D/D |
7,000 |
84,813 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-02-05 |
4 |
B |
$5.77 |
$10,675 |
D/D |
1,850 |
86,663 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-02-25 |
4 |
B |
$5.46 |
$27,300 |
D/D |
5,000 |
91,663 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-03-28 |
4 |
B |
$5.11 |
$3,066 |
D/D |
600 |
92,263 |
2.31 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-03-29 |
4 |
B |
$5.11 |
$7,154 |
D/D |
1,400 |
93,663 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-04-15 |
4 |
B |
$4.52 |
$4,520 |
D/D |
1,000 |
94,663 |
2.31 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-06-17 |
4 |
B |
$5.88 |
$17,640 |
D/D |
3,000 |
97,663 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-06-18 |
4 |
B |
$5.83 |
$11,660 |
D/D |
2,000 |
99,663 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2019-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
109,663 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2020-02-25 |
4 |
B |
$9.31 |
$93,100 |
D/D |
10,000 |
119,663 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2020-02-26 |
4 |
B |
$8.73 |
$1,406 |
D/D |
161 |
119,824 |
2.31 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2020-02-27 |
4 |
B |
$8.20 |
$19,680 |
D/D |
2,400 |
122,224 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
132,224 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2021-05-06 |
4 |
B |
$3.99 |
$9,975 |
D/D |
2,500 |
134,724 |
2.39 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
69,020 |
183,744 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
Director |
– • – |
2017-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
60,000 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
